基本説明
Supplement Issur: 'European Urology 2001, Vol. 39, Suppl. 4'.
Contents
Epidemiology of prostate cancer; the role of intraductal carcinoma in the natural history of prostatic adenocarcinoma; morphogenesis of prostate cancer; the molecular pathogenesis of prostate cancer - focus on the earliest steps; hereditary prostate cancer in Germany; familial aggregation of prostate cancer management while waiting for the identification of hereditary prostate cancer genes; secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy; expectant management of prostate cancer with curative intent; detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients; high-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens; randomized screening trial for prostate cancer in Finland; tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers; latent prostate carcinoma in a screened population; human prostate cancer blocks the generation of dendritic cells from CD34+ hematopoietic progenitors; latent carcinoma of the prostate; consideration of low PSA cut-off levels to optimize the detection of curable prostate cancer; role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer; diagnosis, characterization and potential clinical relevance of prostate cancer detected at low PSA ranges.
